These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32617076)

  • 21. Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system.
    Ala M
    Int Rev Immunol; 2022; 41(3):326-345. PubMed ID: 34289794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets.
    van Herk EH; Te Velde AA
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1393-404. PubMed ID: 26990130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of probiotics and gut microbiota on Th17 cells.
    Tanabe S
    Int Rev Immunol; 2013; 32(5-6):511-25. PubMed ID: 24094077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy.
    Li Z; Vermeire S; Bullens D; Ferrante M; Van Steen K; Noman M; Rutgeerts P; Ceuppens JL; Van Assche G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2418-28. PubMed ID: 26308438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides.
    Hartog A; Belle FN; Bastiaans J; de Graaff P; Garssen J; Harthoorn LF; Vos AP
    J Nutr Biochem; 2015 Mar; 26(3):227-33. PubMed ID: 25498760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan in health and disease.
    Comai S; Bertazzo A; Brughera M; Crotti S
    Adv Clin Chem; 2020; 95():165-218. PubMed ID: 32122523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
    Lord JD; Shows DM; Chen J; Thirlby RC
    PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease.
    Gibson DJ; Ryan EJ; Doherty GA
    Inflamm Bowel Dis; 2013 Nov; 19(12):2716-24. PubMed ID: 23899545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced and natural regulatory T cells in the development of inflammatory bowel disease.
    Mayne CG; Williams CB
    Inflamm Bowel Dis; 2013 Jul; 19(8):1772-88. PubMed ID: 23656897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance.
    Shen X; Du J; Guan W; Zhao Y
    Expert Rev Clin Immunol; 2014 Mar; 10(3):353-62. PubMed ID: 24483245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoregulatory Effects of Elemental Diet and Its Ingredient, Tryptophan, via Activation of the Aryl Hydrocarbon Receptor in Mice.
    Kubota A; Imai S; Aoyagi R; Murase W; Terasaki M; Sugawara M; Takekuma Y; Kojima H
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses.
    Maerz JK; Trostel C; Lange A; Parusel R; Michaelis L; Schäfer A; Yao H; Löw HC; Frick JS
    Front Immunol; 2019; 10():3093. PubMed ID: 32038631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of murine and human Treg subsets in inflammatory bowel disease.
    Sun X; He S; Lv C; Sun X; Wang J; Zheng W; Wang D
    Mol Med Rep; 2017 Sep; 16(3):2893-2898. PubMed ID: 28677759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Environmental influences on T regulatory cells in inflammatory bowel disease.
    Hardenberg G; Steiner TS; Levings MK
    Semin Immunol; 2011 Apr; 23(2):130-8. PubMed ID: 21295492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?
    Fantini MC; Monteleone G
    Inflamm Bowel Dis; 2017 Oct; 23(10):1682-1688. PubMed ID: 28906289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Foxp3-Positive Regulatory T Cell Number in the Intestine of Dogs With Idiopathic Inflammatory Bowel Disease and Intestinal Lymphoma.
    Maeda S; Ohno K; Fujiwara-Igarashi A; Uchida K; Tsujimoto H
    Vet Pathol; 2016 Jan; 53(1):102-12. PubMed ID: 26173451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kynurenine elevation correlates with T regulatory cells increase in acute Plasmodium vivax infection: A pilot study.
    Dos Santos RO; Gonçalves-Lopes RM; Lima NF; Scopel KKG; Ferreira MU; Lalwani P
    Parasite Immunol; 2020 Mar; 42(3):e12689. PubMed ID: 31799743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Th17 cell population and the immune homeostasis of the gastrointestinal tract.
    Rossi M; Bot A
    Int Rev Immunol; 2013; 32(5-6):471-4. PubMed ID: 24164337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.